TD Cowen Initiates Orchestra BioMed (OBIO), Cites High-Margin Potential in Lead Cardiovascular Programs
Orchestra BioMed Holdings Inc. (NASDAQ:OBIO) is one of the best biotech penny stocks to buy according to analysts.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Perceptive Advisors Joseph Edelman | 5,037,906 | $21,738,564 | 0.33% | |
| 2. | Alyeska Investment Group Anand Parekh | 1,000,000 | $4,315,000 | 0.01% | |
| 3. | Propel Bio Management Leen Kawas And Richard Kayne | 896,701 | $3,869,265 | 2.02% | |
| 4. | Dorset Management David M. Knott | 253,651 | $1,094,504 | 0.58% | |
| 5. | DAFNA Capital Management Nathan Fischel | 126,841 | $547,319 | 0.1% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.79 | 10,000 | $47,900.00 | 1,070,746 | 2026-09-03 | Filing | |
| $5.33 | 2,000 | $10,660.00 | 2,000 | 2026-08-26 | Filing | |
| $3.83 | 5,000 | $19,150.00 | 1,064,029 | 2026-06-01 | Filing | |
| $3.75 | 665 | $2,493.75 | 118,118 | 2026-05-18 | Filing | |
| $3.90 | 8,971 | $34,986.90 | 117,453 | 2026-05-15 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.94 | 15,000 | $74,100.00 | 1,134,402 | 2026-09-01 | Filing | |
| $4.09 | 15,000 | $61,350.00 | 1,154,327 | 2026-08-03 | Filing | |
| $4.27 | 15,000 | $64,050.00 | 1,169,327 | 2026-07-01 | Filing | |
| $3.87 | 15,000 | $58,050.00 | 1,184,327 | 2026-06-01 | Filing | |
| $4.13 | 32 | $132.16 | 9,556,063 | 2026-04-27 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,556,063 | $41,234,412 | 0.35% | |
| 2. | 2,510,387 | $10,832,320 | 0% | |
| 3. | 2,022,916 | $8,728,883 | 0% | |
| 4. | 1,007,908 | $4,350,317 | 0% | |
| 5. | 642,154 | $2,770,895 | 0% |